Federica Capozzi

690 total citations
8 papers, 450 citations indexed

About

Federica Capozzi is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Federica Capozzi has authored 8 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 3 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Federica Capozzi's work include Vascular Tumors and Angiosarcomas (2 papers), Sarcoma Diagnosis and Treatment (2 papers) and Neuroblastoma Research and Treatments (2 papers). Federica Capozzi is often cited by papers focused on Vascular Tumors and Angiosarcomas (2 papers), Sarcoma Diagnosis and Treatment (2 papers) and Neuroblastoma Research and Treatments (2 papers). Federica Capozzi collaborates with scholars based in Italy and United States. Federica Capozzi's co-authors include Dario Sangiolo, Ymera Pignochino, Giovanni Grignani, Massimo Aglietta, Lorenzo D’Ambrosio, Franca Fagioli, Piero Picci, Marco Gambarotti, Emanuela Marchesi and Paolo G. Casali and has published in prestigious journals such as The Lancet Oncology, Clinical Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Federica Capozzi

7 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Federica Capozzi Italy	6	255	187	169	79	52	8	450
Kelly M. Bailey United States	11	137 0.5×	179 1.0×	278 1.6×	115 1.5×	18 0.3×	30	552
Akihiro Hemmi Japan	12	136 0.5×	99 0.5×	167 1.0×	53 0.7×	27 0.5×	40	480
Kristelle Lusby United States	8	212 0.8×	99 0.5×	88 0.5×	35 0.4×	26 0.5×	9	342
Takehisa Suzuki Japan	12	146 0.6×	132 0.7×	218 1.3×	87 1.1×	45 0.9×	28	433
Yuichi Terado Japan	12	126 0.5×	106 0.6×	104 0.6×	32 0.4×	55 1.1×	27	367
Yongkui Lu China	11	259 1.0×	350 1.9×	220 1.3×	145 1.8×	108 2.1×	20	657
Jingnan Shen China	13	149 0.6×	93 0.5×	150 0.9×	50 0.6×	30 0.6×	29	449
Daxing Zhu China	13	158 0.6×	174 0.9×	140 0.8×	94 1.2×	19 0.4×	58	469
Jasmien Wellens Belgium	14	304 1.2×	149 0.8×	114 0.7×	43 0.5×	25 0.5×	29	479
Eugene A. Choi United States	10	106 0.4×	257 1.4×	137 0.8×	65 0.8×	30 0.6×	17	491

Countries citing papers authored by Federica Capozzi

Since Specialization

Citations

This map shows the geographic impact of Federica Capozzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Federica Capozzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Federica Capozzi more than expected).

Fields of papers citing papers by Federica Capozzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Federica Capozzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Federica Capozzi. The network helps show where Federica Capozzi may publish in the future.

Co-authorship network of co-authors of Federica Capozzi

This figure shows the co-authorship network connecting the top 25 collaborators of Federica Capozzi. A scholar is included among the top collaborators of Federica Capozzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Federica Capozzi. Federica Capozzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Borrelli, Silvio, et al.. (2023). Sodium-glucose cotransporter-2 inhibition in a CKD patient with severe heart failure treated by high-dose diuretics and peritoneal ultrafiltration: lesson for the clinical nephrologist. Journal of Nephrology. 37(1). 199–201.

Borrelli, Silvio, Federica Capozzi, Michele Provenzano, et al.. (2022). Chronic Hyperkaliemia in Chronic Kidney Disease: An Old Concern with New Answers. International Journal of Molecular Sciences. 23(12). 6378–6378. 11 indexed citations

Mesiano, Giulia, Giovanni Grignani, Erika Fiorino, et al.. (2018). Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy.. OncoImmunology. 7(11). e1465161–e1465161. 23 indexed citations

Pignochino, Ymera, Carmine Dell’Aglio, Simona Inghilleri, et al.. (2015). The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma. BMC Cancer. 15(1). 374–374. 26 indexed citations

Grignani, Giovanni, Emanuela Palmerini, Virginia Ferraresi, et al.. (2014). Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial. The Lancet Oncology. 16(1). 98–107. 260 indexed citations

Pignochino, Ymera, Carmine Dell’Aglio, Marco Basiricò, et al.. (2013). The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 Upregulation in Osteosarcoma Preclinical Models. Clinical Cancer Research. 19(8). 2117–2131. 91 indexed citations

Zak, Frederick G., K Jindrák, & Federica Capozzi. (1983). Carcinoidal lumor of the Kidney. Ultrastructural Pathology. 4(1). 51–59. 34 indexed citations

Capozzi, Federica, et al.. (1972). [Controlled studies of the clinical effects of acetylcysteine in oral administration in respiratory infections in pediatrics].. PubMed. 24(26). 1075–84. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact